Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
GHSI Stock Summary
Top 10 Correlated ETFs
GHSI
In the News
What made Guardion Health stock double on Wednesday?
Guardion Health Sciences Inc (NASDAQ: GHSI) is up nearly 100% this morning after Doctor's Best Inc agreed to buy its Activ Nutritional LLC. Could Guardion Health stock climb any further?
7 Penny Stocks That Actually Have Buy Ratings
This article focuses on penny stocks with “buy” ratings from analysts. Analysts have access to information about companies that retail investors cannot obtain.
7 Undervalued Penny Stocks to Buy for Massive Gains
These seven undervalued penny stocks each have the potential to pay off for investors down later down the road. The post 7 Undervalued Penny Stocks to Buy for Massive Gains appeared first on InvestorPlace.
Best Penny Stocks to Watch as the Market Turns Bullish Today
Which penny stocks are you watching today? The post Best Penny Stocks to Watch as the Market Turns Bullish Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Guardion Health Sciences to Present at the Planet MicroCap Showcase 2022
HOUSTON, May 03, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI), a clinical nutrition company that develops clinically supported nutrition, medical foods, and supplements, announces today that Chief Executive Officer Bret Scholtes will present a corporate overview at the Planet MicroCap Showcase 2022. The conference is being held on May 3 – 5, 2022 at The Bally's Hotel & Casino in Las Vegas, NV.
4 Top Penny Stocks To Buy For Under $1 This Week
Penny stocks to watch under $1 this week. The post 4 Top Penny Stocks To Buy For Under $1 This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Trading Penny Stocks? Top Stock Market News for March 2nd, 2022
Here's what you need to know about trading penny stocks on March 2nd The post Trading Penny Stocks? Top Stock Market News for March 2nd, 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Hot Penny Stocks To Buy For Under $1 In March 2022
Hot penny stocks to buy for under $1. Are they worth it in March 2022?
GHSI Stock: 12 Things to Know About Guardion Health Science as Shares Rocket
Guardion Health Science (GHSI) stock is taking off on Wednesday thanks to a presentation taking place today and heavy trading. The post GHSI Stock: 12 Things to Know About Guardion Health Science as Shares Rocket appeared first on InvestorPlace.
Guardion Health Sciences Stockholders Urged to Vote Their Shares for October 22, 2021 Annual Meeting
HOUSTON, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically supported nutrition, medical foods, supplements, and medical devices, urges stockholders to vote their shares for the Company's Annual Meeting of Stockholders on October 22, 2021 by 11:59PM ET on October 21, 2021.
GHSI Financial details
GHSI Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 12.78 | 7.43 | 6.63 | 15.27 | 9.05 | |
Net income per share | -105.39 | -91.61 | -30.09 | -52.23 | -24.79 | |
Operating cash flow per share | -56.63 | -49.61 | -28.11 | -22.47 | -6.1 | |
Free cash flow per share | -60.84 | -51.01 | -28.25 | -22.62 | -6.1 | |
Cash per share | 9.1 | 91.44 | 29.88 | 19.19 | 8.72 | |
Book value per share | 43.22 | 98.98 | 29.86 | 47.06 | 10.78 | |
Tangible book value per share | 15.82 | 98.57 | 29.69 | 23.31 | 10.78 | |
Share holders equity per share | 43.22 | 98.98 | 29.86 | 47.06 | 10.78 | |
Interest debt per share | 0.03 | 6.95 | 1.55 | 0.05 | 12.58 | |
Market cap | 81.37M | 8.02M | 35.5M | 15.33M | 8.85M | |
Enterprise value | 80.7M | -2.51M | 27.42M | 11.26M | -1.8M | |
P/E ratio | -10.48 | -0.72 | -4.14 | -0.62 | -0.29 | |
Price to sales ratio | 86.36 | 8.89 | 18.78 | 2.12 | 0.8 | |
POCF ratio | -19.49 | -1.33 | -4.43 | -1.44 | -1.19 | |
PFCF ratio | -18.15 | -1.29 | -4.41 | -1.43 | -1.19 | |
P/B Ratio | 25.54 | 0.67 | 4.17 | 0.69 | 0.67 | |
PTB ratio | 25.54 | 0.67 | 4.17 | 0.69 | 0.67 | |
EV to sales | 85.65 | -2.78 | 14.51 | 1.56 | -0.16 | |
Enterprise value over EBITDA | -13.8 | 0.29 | -3.31 | -1.18 | -1.07 | |
EV to operating cash flow | -19.33 | 0.42 | -3.42 | -1.06 | 0.24 | |
EV to free cash flow | -18 | 0.4 | -3.4 | -1.05 | 0.24 | |
Earnings yield | -0.1 | -1.39 | -0.24 | -1.61 | -3.42 | |
Free cash flow yield | -0.06 | -0.77 | -0.23 | -0.7 | -0.84 | |
Debt to equity | 0 | 0.05 | 0.05 | 0 | 0 | |
Debt to assets | 0 | 0.05 | 0.04 | 0 | 0 | |
Net debt to EBITDA | 0.11 | 1.21 | 0.98 | 0.42 | -6.33 | |
Current ratio | 2.23 | 28.93 | 8.47 | 10.41 | 5.39 | |
Interest coverage | -2.68K | -34.58 | -1.18K | 0 | 0.03 | |
Income quality | 0.54 | 0.55 | 0.93 | 0.43 | 0.5 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 5.24 | 8.22 | 3.62 | 1.55 | 0.87 | |
Research and developement to revenue | 0.25 | 0.22 | 0.09 | 0.01 | 0.02 | |
Intangibles to total assets | 0.55 | 0 | 0.01 | 0.48 | 0 | |
Capex to operating cash flow | 0.07 | 0.03 | 0.01 | 0.01 | 0 | |
Capex to revenue | -0.33 | -0.19 | -0.02 | -0.01 | 0 | |
Capex to depreciation | -1.05 | -0.27 | -0.19 | -0.08 | 0 | |
Stock based compensation to revenue | 1.69 | 3.01 | -0.21 | 0.18 | 0.03 | |
Graham number | 320.15 | 451.69 | 142.18 | 235.18 | 77.55 | |
ROIC | -1.53 | -0.69 | -0.91 | -0.47 | 0.07 | |
Return on tangible assets | -4.68 | -0.87 | -0.87 | -2.03 | -1.4 | |
Graham Net | 5.1 | 86.25 | 25.86 | 19.35 | 4.21 | |
Working capital | 609.58K | 11.46M | 8.02M | 10.91M | 17.63M | |
Tangible asset value | 1.17M | 11.98M | 8.47M | 11.04M | 13.17M | |
Net current asset value | 609.58K | 11.02M | 7.75M | 10.91M | 13.12M | |
Invested capital | 0 | 0.05 | 0.05 | 0 | 0 | |
Average receivables | 50.49K | 53.27K | 44.79K | 711.41K | 1.67M | |
Average payables | 362.58K | 271.53K | 368.72K | 424.83K | 879.7K | |
Average inventory | 256.36K | 334.47K | 347.96K | 376.33K | 1.74M | |
Days sales outstanding | 10.93 | 31.67 | 2.17 | 71.23 | 63.57 | |
Days payables outstanding | 379.43 | 138.09 | 114.06 | 21.37 | 84.86 | |
Days of inventory on hand | 328.17 | 332.52 | 72.18 | 32.55 | 174.38 | |
Receivables turnover | 33.41 | 11.53 | 168.02 | 5.12 | 5.74 | |
Payables turnover | 0.96 | 2.64 | 3.2 | 17.08 | 4.3 | |
Inventory turnover | 1.11 | 1.1 | 5.06 | 11.21 | 2.09 | |
ROE | -2.44 | -0.93 | -1.01 | -1.11 | -2.3 | |
Capex per share | -4.21 | -1.41 | -0.14 | -0.16 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.17 | 2.23 | 2.51 | 2.2 | 2.62 | |
Net income per share | -1.35 | -19.85 | 2 | -0.93 | 0.29 | |
Operating cash flow per share | -1.04 | -1.12 | -1.48 | -0.32 | -0.6 | |
Free cash flow per share | -1.05 | -1.12 | -1.48 | -0.32 | -0.6 | |
Cash per share | 10.54 | 8.72 | 6.92 | 6.6 | 6.01 | |
Book value per share | 21.57 | 10.78 | 6.69 | 5.71 | 6.05 | |
Tangible book value per share | 13.13 | 10.78 | 6.69 | 5.71 | 6.05 | |
Share holders equity per share | 21.57 | 10.78 | 6.69 | 5.71 | 6.05 | |
Interest debt per share | 0.04 | 12.56 | -1.58 | 0 | 0 | |
Market cap | 8.47M | 8.85M | 7.74M | 9.86M | 9.4M | |
Enterprise value | -4.46M | -1.8M | -1.03M | 1.49M | 1.74M | |
P/E ratio | -1.27 | -0.09 | 0.77 | -2.1 | 6.31 | |
Price to sales ratio | 3.18 | 3.25 | 2.43 | 3.53 | 2.82 | |
POCF ratio | -6.61 | -6.49 | -4.12 | -24.26 | -12.26 | |
PFCF ratio | -6.59 | -6.49 | -4.12 | -24.13 | -12.26 | |
P/B Ratio | 0.32 | 0.67 | 0.91 | 1.36 | 1.22 | |
PTB ratio | 0.32 | 0.67 | 0.91 | 1.36 | 1.22 | |
EV to sales | -1.68 | -0.66 | -0.32 | 0.54 | 0.52 | |
Enterprise value over EBITDA | 3.17 | -0.27 | 0.31 | -1.99 | -0.96 | |
EV to operating cash flow | 3.48 | 1.32 | 0.55 | -3.68 | -2.27 | |
EV to free cash flow | 3.47 | 1.32 | 0.55 | -3.66 | -2.27 | |
Earnings yield | -0.2 | -2.74 | 0.33 | -0.12 | 0.04 | |
Free cash flow yield | -0.15 | -0.15 | -0.24 | -0.04 | -0.08 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 9.18 | -1.58 | 2.61 | 11.12 | 4.21 | |
Current ratio | 10.28 | 5.39 | 6.6 | 6.73 | 8.97 | |
Interest coverage | -39.97 | 0.42 | 0.73 | 0 | 0 | |
Income quality | 0.76 | 0.15 | -3.53 | 0.35 | -2.06 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.84 | 0.62 | 0.67 | 0.63 | 0.57 | |
Research and developement to revenue | 0.02 | 0.01 | 0.02 | 0.03 | 0 | |
Intangibles to total assets | 0.37 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0.01 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | -0.01 | 0 | -0.35 | -0.44 | 0 | |
Stock based compensation to revenue | 0.02 | 0.01 | 0.01 | -0.02 | 0.01 | |
Graham number | 25.63 | 69.4 | 17.34 | 10.91 | 6.31 | |
ROIC | -0.06 | 1.33 | -0.82 | -0.16 | -0.41 | |
Return on tangible assets | -0.09 | -1.12 | 0.18 | -0.09 | 0.03 | |
Graham Net | 11.07 | 4.21 | 4.6 | 3.59 | 3.95 | |
Working capital | 16.08M | 17.63M | 12.19M | 11.43M | 11.41M | |
Tangible asset value | 16.13M | 13.17M | 8.48M | 7.24M | 7.7M | |
Net current asset value | 16.08M | 13.12M | 8.44M | 7.2M | 7.66M | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 1.94M | 1.9M | 1.94M | 1.75M | 1.66M | |
Average payables | 1.07M | 1.28M | 1.2M | 936.95K | 933.46K | |
Average inventory | 1.83M | 2.54M | 3.09M | 2.79M | 2.48M | |
Days sales outstanding | 63.31 | 63.52 | 55 | 50.17 | 47.63 | |
Days payables outstanding | 59.45 | 76.32 | 43.22 | 57.56 | 42.27 | |
Days of inventory on hand | 111.57 | 156.83 | 148.88 | 146.81 | 117.51 | |
Receivables turnover | 1.42 | 1.42 | 1.64 | 1.79 | 1.89 | |
Payables turnover | 1.51 | 1.18 | 2.08 | 1.56 | 2.13 | |
Inventory turnover | 0.81 | 0.57 | 0.6 | 0.61 | 0.77 | |
ROE | -0.06 | -1.84 | 0.3 | -0.16 | 0.05 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
GHSI Frequently Asked Questions
What is Guardion Health Sciences, Inc. stock symbol ?
Guardion Health Sciences, Inc. is a US stock , located in San diego of Ca and trading under the symbol GHSI
Is Guardion Health Sciences, Inc. buy or a sell ?
1 stock analysts have 1 predictions with a medium analyst target price of $0.01. The lowest prediction is $0.012 and the highest is $0.012
What is GHSI stock prediction ?
What is Guardion Health Sciences, Inc. stock quote today ?
Guardion Health Sciences, Inc. stock price is $9.01 today.
Is Guardion Health Sciences, Inc. stock public?
Yes, Guardion Health Sciences, Inc. is a publicly traded company.